Valuation of life sciences companies has been battered and the IPO window has closed, for now. But there are still plenty of strategic partners looking for promising new technology and life sciences companies to fill their pipelines. If you want
Crowley Law New Frontier
Valuation of life sciences companies has been battered and the IPO window has closed, for now. But there are still plenty of strategic partners looking for promising new technology and life sciences companies to fill their pipelines. If you want